Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study
- PMID: 25378672
- PMCID: PMC4277678
- DOI: 10.1212/WNL.0000000000001067
Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study
Abstract
Objective: To evaluate adiponectin and leptin levels in older men and women with migraine.
Methods: Fasting total and high molecular weight (HMW) adiponectin and leptin levels were evaluated in a case-cohort study of nondiabetic older migraine and nonmigraine control participants from the ongoing, longitudinal, general population, Atherosclerosis Risk in Communities Study at visit 1 (1987-1989). A standardized headache questionnaire was completed at visit 3 (1993-1995). Logistic regression models adjusted for age, sex, race, center, body mass index, and fasting glucose were used to evaluate the association of each adipocytokine with migraine.
Results: Of the 981 participants, the mean age at baseline was 52.8 years (SE 0.3); 131 fulfilled migraine criteria. Crude, mean total adiponectin levels were greater in men and women with migraine (8.1 µg/mL, SE 0.5) as compared to those without migraine (7.0 µg/mL, SE 0.2) (p = 0.031). After adjustments, the odds of migraine were increased by 88% with each SD increase in total adiponectin in men (odds ratio [OR] 1.86; 95% confidence interval [CI] 1.15, 3.01; p = 0.011), but not in women (OR 1.05; 95% CI 0.80, 1.37; p = 0.728; p interaction = 0.029). Similar results were demonstrated for HMW adiponectin. Crude and adjusted leptin levels were not associated with migraine.
Conclusions: Although crude, total adiponectin levels were higher in older men and women with migraine than controls, after adjustments, the prevalence of migraine was significantly associated with total adiponectin only in older men, suggesting the association may be confounded or absent in older women. Leptin was not associated with migraine in older men or women.
© 2014 American Academy of Neurology.
Figures

Comment in
-
Inflaming the need for migraine biomarkers.Neurology. 2014 Dec 9;83(24):2198-9. doi: 10.1212/WNL.0000000000001085. Epub 2014 Nov 5. Neurology. 2014. PMID: 25378680 No abstract available.
-
Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study.Neurology. 2015 Aug 4;85(5):482. doi: 10.1212/WNL.0000000000001797. Neurology. 2015. PMID: 26238820 No abstract available.
-
Adiponectin and leptin levels in migraineurs in the Atherosclerosis Risk in Communities Study--author response.Neurology. 2015 Aug 4;85(5):482. Neurology. 2015. PMID: 26468557 No abstract available.
References
-
- Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614–620. - PubMed
-
- Rainero I, Limone P, Ferrero M, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005;25:593–597. - PubMed
-
- Ward TN. Migraine diagnosis and pathophysiology. Continuum 2012;18:753–763. - PubMed
-
- D'Andrea G, Leon A. Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond. Neurol Sci 2010;31(suppl 1):S1–S7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous